Author

Anne-Florence Collange

Hôpital Necker-Enfants Malades

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:proteomics· 1

Frequent Co-Authors

Amélie Bigorgne· 1 shared Angélique Lebouvier· 1 shared C. MéniiD· 1 shared Caroline Kabore· 1 shared Christine BodemeriD· 1 shared Cristina Bulai LivideanuiD· 1 shared Darragh DuffyiD· 1 shared Éric SolaryiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Amélie Bigorgne

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

AXL mediates mast cell survival and resistance to tyrosine kinase inhibitors in mastocytosis

Kitsada Kangboonruang, Philippe Drabent, Fatlinda Maksut, Maxime Heintzé, Yves Lepelletier, Ludovic Lhermitte, Mélanie Féroul, Sébastien Letard, Caroline Kabore, Fabienne A. Brenet, C. Méni, Nicolas Cagnard, Vincent Bondet, Guillaume Lefèvre, Julie Bruneau, , Leïla Maouche-Chrétien

This study identifies AXL as a driver of mast cell survival and TKI resistance in mastocytosis and shows that dual KIT/AXL inhibition restores TKI sensitivity.

bioRxiv · Nov 3, 2025 · PreprintCancer Biology